Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway

PLoS ONE

Volumn 2, Issue 5, 2007, Pages

  Sadis, Claude ^a,d   Teske, Gwen ^b   Stokman, Geurt ^b   Kubjak, Carole ^a   Claessen, Nike ^b   Moore, Fabrice ^a   Loi, Patrizia ^a   Diallo, Bilo ^c   Barvais, Luc ^d   Goldman, Michel ^a   Florquin, Sandrine ^b   Le Moine, Alain ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c BIOVALLEE   (Belgium)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CASPASE 3; HIGH MOBILITY GROUP B1 PROTEIN; KI 67 ANTIGEN; NICOTINE; TUMOR NECROSIS FACTOR ALPHA; ALPHA-BUNGAROTOXIN RECEPTOR; AUTACOID; NICOTINIC RECEPTOR;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; INFLAMMATION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RENAL PROTECTION; REPERFUSION INJURY; SINGLE DRUG DOSE; TUBULAR DYSFUNCTION; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECT; GENETICS; KIDNEY; MOUSE MUTANT; PATHOPHYSIOLOGY; PH; PHYSIOLOGY; VASCULARIZATION; WESTERN BLOTTING;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; HYDROGEN-ION CONCENTRATION; INFLAMMATION MEDIATORS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINE; RECEPTORS, NICOTINIC; REPERFUSION INJURY;

EID: 36448958155     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000469     Document Type: Article

References (31)

1. Gill N, Nally JV Jr, Fatica RA (2005) Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest 128: 2847-2863.
2. Joosten SA, Sijpkens YW, van Kooten C, Paul LC (2005) Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 68: 1-13.
3. Bonventre JV, Zuk A (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485.
4. Boros P, Bromberg JS (2006) New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 6: 652-658.
5. Lien YH, Lai LW, Silva AL (2003) Pathogenesis of renal ischemia/ reperfusion injury: lessons from knockout mice. Life Sci 74: 543-552.
6. Lieberthal W, Nigam SK (2000) Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 278: F1-F12.
7. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903.
8. Rouschop KM, Roelofs JJ, Claessen N, da Costa MP, Zwaginga JJ, et al. (2005) Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 16: 2034-2043.
9. Tracey KJ (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117: 289-296.
10. Metz CN, Tracey KJ (2005) It takes nerve to dampen inflammation. Nat Immunol 6: 756-757.
11. Tracey KJ (2002) The inflammatory reflex. Nature 420: 853-859.
12. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
13. van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, et al. (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130: 1822-1830.
14. van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, et al. (2005) The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 191: 2138-2148.
15. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, et al. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201: 1113-1123.
16. Wang H, Liao H, Ochani M, Justiniani M, Lin X, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
17. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, et al. (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143.
18. Izuishi K, Tsung A, Jeyabalan G, Critchlow ND, Li J, et al. (2006) Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol 176: 7154-7158.
19. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, et al. (2006) High mobility group box-1 (HMGB1) protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol.
20. Yu M, Wang H, Ding A, Golenbock DT, Latz E, et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174-179.
21. Daemen MA, de Vries B, van't Veer C, Wolfs TG, Buurman WA (2001) Apoptosis and chemokine induction after renal ischemia-reperfusion. Transplantation 71: 1007-1011.
22. Serobyan N, Schraufstatter IU, Strongin A, Khaldoyanidi SK (2005) Nicotinic acetylcholine receptor-mediated stimulation of endothelial cells results in the arrest of haematopoietic progenitor cells on endothelium. Br J Haematol 129: 257-265.
23. Ulloa L (2005) The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4: 673-684.
24. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
25. Qin S, Wang H, Yuan R, Li H, Ochani M, et al. (2006) Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 203: 1637-1642.
26. Mai H, May WS, Gao F, Jin Z, Deng X (2003) A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 278: 1886-1891.
27. Toborek M, Son KW, Pudelko A, King-Pospisil K, Wylegala E, et al. (2006) ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons. J Cell Biochem 100: 279-292.
28. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, et al. (2006) Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103: 6332-6337.
29. Sener G, Sehirli O, Ipci Y, Cetinel S, Cikler E, et al. (2005) Protective effects of taurine against nicotine-induced oxidative damage of rat urinary bladder and kidney. Pharmacology 74: 37-44.
30. Thomas GA, Rhodes J, Ingram JR (2005) Mechanisms of disease: nicotine-a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2: 536-544.
31. Crockett ET, Galligan JJ, Uhal BD, Harkema J, Roth R, et al. (2006) Protection of early phase hepatic ischemia-reperfusion injury by cholinergic agonists. BMC Clin Pathol 6: 3.